Training and Education
Tailor made transduction-ready viral particles
AMSBIO offers a production service for high quality custom transduction-ready viral particles designed to support your research and save you valuable time.
Drawing upon extensive knowledge in research areas including Adeno Associated Virus, Adenovirus, Herpes Simplex Virus, Lentivirus, MMLV Retrovirus...
Revolutionising organoid manufacturing
Monmouth Scientific Class 2 Biological Safety Cabinets enhance sterility and efficiency at Molecular Devices' new Life Science facility.
Global life science and 3D biology pioneers Molecular Devices has launched a groundbreaking facility in Cardiff, dedicated to research, development and industrial-scale...
Scientists at Norwich Research Park developing infection-resistant chest drain
Scientists at Norwich Research Park are working together to design an infection-resistant chest drain for patients with advanced cancer being treated for pleural effusions. Pleural effusion occurs when fluid builds up in the space between the lung and the...
Sensitive detection of cell culture mycoplasma infection
The MycoScope™ Mycoplasma PCR detection kit from AMSBIO uses polymerase chain reaction (PCR) technology to detect mycoplasma infections in less than 3 hours. Offering high-sensitivity detection, rapid results, and compatibility with existing PCR setups, this kit reduces the risk...
What is GMP Cleanroom Consultancy?
Whether you’re new to, or an expert in the world of GMP, ensuring you are operating to the correct standards and your cleanroom is qualified and maintained appropriately can be a difficult, ongoing task for anyone!
In this blog, we’ll...
Revolutionising Pharmaceutical Water Management: The Power of Water as a Service (WaaS)
In the constantly evolving world of pharmaceutical research, where accuracy and regulatory adherence are crucial, water quality plays an undeniably pivotal role. Veolia Water Technologies presents an innovative solution designed specifically for the pharmaceutical industry – Water as a...
Culture techniques for drug discovery and therapeutics
AMSBIO has published an informative online article that reviews the importance of culture techniques for induced pluripotent stem cells (iPSCs), which provide an invaluable resource for drug discovery and therapeutic applications.
When using iPSCs for drug discovery and therapeutic applications,...
Intuitive software for multi-detector GPC/SEC
ParSEC Advanced software from TESTA Analytical is designed to acquire and analyze data from GPC /SEC systems fitted with any combination of refractive index, light scattering, UV, and viscosity detectors.
Traditionally the complexity of data acquisition, storage, visualization, analysis, and...
ADC & Radiopharmaceuticals Pharma & Biotech Partnering Summit – Your Partnering Opportunity for 2024!
Major moves in the pharma and biotech partnering are reshaping the landscape. For ADC companies, the challenge lies in standing out, validating their offerings, and securing clinical-ready assets amidst this whirlwind of activity.
How does one differentiate and obtain assets...
Angstrom Technology Awarded Best Cleanrooms Solutions Company 2024 at the International Life Sciences Awards
Global cleanroom solutions provider, Angstrom Technology has received the Best Cleanrooms Solutions Company Award at the International Life Sciences Awards 2024.
GHP magazine’s International Life Sciences Awards programme recognises those that are going above and beyond, or indeed, the businesses...
Genetically engineered iPSCs offer improved efficiency and cost savings.
AMSBIO has launched a range of genetically engineered Induced Pluripotent Stem Cells (iPSCs) developed to provide improved model fidelity over cell lines and biochemical assays used for drug discovery and cell therapy research.
These iPSC cell lines offer improved efficiency...
Sourcing, growing, and differentiating human skeletal muscle cells.
AMSBIO offers a wide range of products to support skeletal muscle cell culture enabling you to streamline your modelling process in vitro.
Skeletal muscle accounts for 30-40% of the weight in a healthy individual. However, it is also a key...
Life Sciences SECTOR faceS ‘perfect storm’
Sector must work together to de-risk funding in medicines discovery and attract more investors, new study warns.
A report by Medicines Discovery Catapult (MDC), in partnership with the UK BioIndustry Association and the Association of the British Pharmaceutical Industry, highlights...
Mission Genomics to launch the UK economy
UK-wide genetic testing will boost health, save lives, and create a new pathway for economic innovation, says Dr Stuart J. Grice, co-founder and CSO at FitnessGenes.
The United Kingdom is at the forefront of genomics research. Initiatives like the UK...
Genes could ensure right sepsis treatment, faster
Sepsis patients could be treated based on their immune system’s response to infection, not their symptoms.
New research uncovers how different people respond to sepsis based on their genetic makeup, which could help identify who would benefit from certain treatments...
World-first generative AI tool designs enzymes for more sustainable industrial processes
ZymCTRL is the world’s first open-source, text-based enzyme generation model and can be used across multiple industries, including therapeutics and sustainability initiatives. The AI model can produce sequences that create functional enzymes with desirable characteristics for industrial applications.
ZymCTRL (“enzyme...
First UK trial of Deep Brain Stimulation for children with epilepsy
A 13-year-old boy has made history as the first patient in the UK to take part in a clinical trial using deep brain stimulation (DBS) to treat epilepsy.
Since the procedure, Oran’s daytime seizures have decreased by 80%, significantly improving...
Robotic ‘nerve cuffs’ could treat neurological conditions
Researchers have developed tiny, flexible devices that can wrap around individual nerve fibres without damaging them.
Researchers from the University of Cambridge have combined flexible electronics and soft robotics techniques to develop the devices, which could be used for the...
Major milestone for North East Investment Zone at NETPark Phase 3
The £62million expansion of one of the UK’s premier science parks has taken a significant step towards completion.
The Phase 3 development of the North East Technology Park (NETPark) at Sedgefield reached a major milestone as the last piece of...
Partnership to advance ALS research
A new collaboration is working to expand applications of DNA break-mapping technology and advance understanding of genomic instability in the development of neurodegenerative disease, amyotrophic lateral sclerosis.
The research is being undertaken by Broken String Biosciences (“Broken String”), a genomics...
MONMOUTH SCIENTIFIC: Creating clean air through recirculating technology
At Monmouth Scientific, we are committed to providing solutions that foster a clean and sustainable environment. Our key innovation is the use of recirculating technology, enhanced by activated carbon and HEPA filtration.
UNDERSTANDING RECIRCULATING TECHNOLOGY
Recirculating technology involves the continuous movement...
UK drug companies ‘repeatedly violate marketing code’
New data analysis highlights potential “serious consequences” for patient health and lengthy complaint processing times.
Research by University of Bath and Lund University academics reveals that public health in the UK could be undermined by a failing system of drug...
Initial in vivo validation of novel oncology therapeutic mechanism completed
Oxford Drug Design, an Oxford-based AI drug discovery company using an AI platform to develop novel molecules for use in cancer treatments, has successfully completed the first in vivo validation in its potential first-in-class approach against multiple tumours.
The results...
Enzyme discovery paves way for greener cancer treatments
Scientists from The University of Manchester have uncovered a more efficient and sustainable way to make peptide-based medicines, showing promising effectiveness in combating cancers.
Peptides are comprised of small chains of amino acids, which are also the building blocks of...
Trailblazing scientist is first British winner of Lifetime Achievement Award
British scientist Dame Carol Robinson has received the Lifetime Achievement Award at the European Inventor Award 2024.
The Professor of Chemistry at the University of Oxford is a trailblazer in the field of mass spectrometry and has dedicated her career...
Scientists create tailored drug for aggressive breast cancer
Scientists have used breast cancer cells’ weakness against themselves by linking a tumour-selective antibody with a cell-killing drug to destroy hard-to-treat tumours.
The research, published in Clinical Cancer Research by a team from King’s College London and funded by Breast...
Chicken feathers to deliver chemotherapy drugs and repair enzymes
A new method of drug delivery using proline, an amino acid found in chicken feathers and skin tissue, could be used to limit the side effects of chemotherapy and repair important enzymes, new research suggests.
Published in the journal Chem,...
Breakthrough in creating cyclic peptide opens the way for new antibiotics
A discovery by scientists at King’s College London could speed up efforts to produce new antibiotics in the fight against antimicrobial resistance.
In a paper published in the Journal of the American Chemical Society, scientists from the Department of Chemistry...
How efficient logistics can change the lives of rare disease patients
Dr. Danial Arkwell, Head of Global Key Accounts, Pharma, at Envirotainer, highlights the vital role of efficient logistics in getting orphan drugs to patients in desperate need.
There are approximately 8,000 rare diseases in the world, and many are life-threatening....
UK businesses must enforce ESG compliance in supply chains
New EU supply chain laws still impacting UK firms post-Brexit, and new standards mean UK healthcare and pharmaceutical companies can be legally liable for failure to comply, according to supply chain consultants, INVERTO.
Most companies have already taken steps to...